NCT05899621 2023-06-12A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FLRuijin HospitalRecruiting332 enrolled
NCT03374137 2023-01-12Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic LeukemiaHoffmann-La RocheCompleted55 enrolled